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Abstract 
Problem Statement: Rheumatic diseases carries a high physical, psychological and social impact, with relevant multi-dimensional 
assessment of psychosocial functioning of these rheumatic patients, reasons for carrying out the present study. 
Research Questions: What is the prevalence of anxiety, depression and stress in patients with rheumatoid arthritis? 
Purpose of the Study: This aimed to identify the prevalence of anxiety, depression and stress in people with rheumatoid arthritis 
These have in our population worse quality of life indicators, when compared with the general population. 
Research Methods: The study observational was conducted with 80 participants, 82.5% were female, aged between 21 and 80 
years, with an average of 58.16 years. 
Was applied "Health Assessment Questionnaire" (Fries, 197, validated by Santos Reis, Rebelo, Days, Pink & Queiroz, 1996); 
"Anxiety Scale, Depression and Stress" (PF Lovibond and Lovibond SH, 1995, adapted by Ribeiro, Honored and Leal, 2004). 
Findings: Moderate and high anxiety was found in 37.5% of the sample and severe depressive symptoms in 35%, which are 
higher in women (♀40,9%; ♂39,4%). Stress presented high in 42.5% of subjects. 
The anxiety and depression are higher in the females participants, with increased pain and superior functional impairment. Stress 
increases with the low income and worsening of health status. 
Conclusions: Nursing care to these people should include interventions aimed at screening, referral and treatment of these clinical 
outbreaks. These nosological entities should also be considered when planning educational activities / training of future health 
professionals. 
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1. Introdution 
Rheumatic diseases are amongst the most responsible for health charges, both direct and indirectly, being one of 
the most frequent disease groups in developed countries, constituting the leading cause of medical consultation, the 
leading cause of disability, the first reason for absenteeism from work and the fundamental cause of early retirement 
due to illness (DGS, 2013). 
In most cases, there is an association with pain and disability, with consequent organ dysfunction, activity 
limitations and restrictions in social participation (Lucas & Monjardino, 2010), causing a high impact on the 
physical, psychological and social level, making a multidimensional assessment relevant, required and expected 
(Monjardino, Lucas & Barros, 2013). 
In this group of diseases it is found the rheumatoid arthritis (RA), a chronic, systemic disease of unknown 
etiology which mainly affects joints, consisting of chronic synovial inflammation that leads to joint destruction and 
marked failure (Smith, 2005 ; Goldman, 2012). This nosological entity causes pain and deformities, and may 
progress to severe limitations, forcing people to depend on assistive devices and / or third parties to carry out their 
daily activities (Ribeiro, Schier, Ornelas, Oliveira, Nardi and Silva, 2013). 
Although it can occur at any age, the onset is most frequent between 35 and 50 years of age (Goldman, 2012), 
with prevalence in women being two to three times higher than in men (Smith, 2005; Goldman, 2012, DGS, 2013). 
In Portugal, it was estimated a prevalence of about 0.8% in 2001 with the incidence varying between 2-4 cases 
per 10,000 people each year "(Luke and Monjardino, 2010, p. 112). 
The treatment aims to reduce the impact of disease limiting symptoms, reducing inflammation and disability and 
improving the quality of life, being the main purpose of drug therapy the reduction of the swelling and ultimately 
the disease remission (Mcbain, Shipley and Newman, 2013; DGS, 2011), for the persistence of joint inflammation is 
the originator of structural damages, of functional impotence, disability and reduced life expectancy (DGS, 2011). 
Given the characteristics of chronicity, pain, functional disability and deformity by the disease, the psychosocial 
implications are significant on people's lives and their families, and can cause psychiatric signs and symptoms, 
especially anxiety and depression (Ribeiro, Schiera, Ornelasa, Oliveira, Nardia e Silva, 2013; McBain, Shipley and 
Newman, 2013). 
Higher levels of disease activity, pain and functional disability can lead to more behaviors of depression, anxiety 
and stress, leading consequently to an increased risk of suicide (Ho Fu, Chua, cheak and Mak, 2011). 
 
 
2. Problem Statement  
 Rheumatoid arthritis is a crippling disease, which causes physical deformities and painful limitations, with an 
early beginning, affecting the most productive period of life, damaging professional realization, social and daily life 
activities, which becomes impacting on quality of life and people’s mental health and can lead to negative changes 
in psychological parameters (Salaffi, Carotti, Gasparini, Intorcia, & Grassi, 2009 quoted by Darius Külkamp, 
Faraco, Gevaerd and Domenech, 2010). It was found in several studies an increased occurrence of some mental 
health disorders, particularly anxiety and depression, in people diagnosed with rheumatoid arthritis, with an average 
above the frequency typically found in the general population (Isik, Koca, Ozturk, & Mermi, 2007 Costa, Brazil, 
Papi, & Azevedo, 2008, quoted by Darius Külkamp, Faraco, Gevaerd and Domenech, 2010). In this context, the 
occurrence of co-morbidities such as anxiety, depression and stress in people with rheumatoid arthritis constitute an 
important public health problem that imposes investigation. 
3. Research Questions 
Anxiety and depression have been linked to the epidemiological course of rheumatoid arthritis, and clinical 
practice also supports this nosological occurrence, hence emerges as the central research question for this study 
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What is the prevalence of anxiety, depression and stress in patients with rheumatoid arthritis? 
4. Purpose of the Study 
This study aimed to identify the prevalence of anxiety, depression and stress in people with rheumatoid arthritis, 
as the Portuguese population presents the worse psychosocial well-being indicators and quality of life when 
compared with the general population. 
5. Research Methods 
The quantitative study with descriptive-correlational and cross-sectional approach analysis was conducted with 
80 participants with rheumatoid arthritis, followed in rheumatology consultation in a hospital in the central region of 
Portugal, with an average age of 58.16 years, 82.5 % female. 
The data collection instrument included a sociodemographic and clinical questionnaire. It was also applied the 
Health Assessment Questionnaire Fries (1978), validated by Santos Reis, Rebelo, Days, Pink & Queiroz (1996) for 
the Portuguese population, and the Anxiety, Depression and Stress Scale by PF Lovibond & Lovibond SH (1995, 
adapted by Ribeiro, Honored & Leal (2004). Please note that the use of the respective scales was promptly 
authorized by their respective authors. 
The study complied with the formal, legal and ethical procedures namely: obtained a favorable opinion from the 
Ethics Committee of the hospital and the completion of data collection was also authorized. After assent to conduct 
the study, it took place the data collection, always attending the self-determination and privacy of each participant, 
having obtained of each an informed consent. 
The dependent variables were anxiety, depression and stress, and the independent variables included 
sociodemographic (age, sex, area of residence, educational background, employment status, household income and 
practice of religion) and clinical variables (CRP, VS, painful joints, swollen joints, pain experienced by the patient, 
overall disease activity, according to the patient, biological drugs and functional capacity).  
Statistical analysis was processed through the SPSS 22.0 (Statistical Package for Social Sciences) for Windows. 
 
 
Findings 
 
The socio-demographic analysis of the sample showed that it was mostly made up of female participants (82.5%), 
aged between 21 and 80 years, with an average age of 58.16 years; 81.3% were married or living in de facto unions, 
living in rural areas (65.0%). As for literary qualifications \ Academic 53.8% held the 1st Cycle \ 4th class \ 4th 
year. The whole had a monthly household income similar to the national minimum wage (53.8%) and 42.6% are 
retired (42.6%).  
Clinical analysis of clinical parameters showed that the C-reactive protein (CRP) average value was 0.87, 
corresponding to 58.8% which did not show inflammatory activity, the average speed of sedimentation (VS) was 
10.6, indicating that 90% did not present inflammation. Half the sample (50%) were under the influence of 
biological drugs, 47.5% had one or more painful joints and 58.7% one or more swollen joints. We found an average 
pain perception value of 50mm, similar to the general state of disease according to the patient, which was 52mm. 
Mild disability affected 60% of respondents, while 40% showed moderate to high disability. 
It was found that 37.5% of people with RA had moderate and high anxiety, and 25% mild anxiety, having been 
noticed that men had more mild anxiety compared to women (50.0% vs 19.7%), revealing the residual adjusted 
values significant differences (res = 2.4). 
The majority of people with RA had high levels of high depression (35%) and 33.8% mild depression, and men 
have less depressive symptoms when compared with women (64.3% vs 27.3%), with significant differences (res = 
2.7). 
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The stress level evaluation patented that it was elevated in 45% of people with RA, being light in 42.5% and mild 
in 12.5%. Men scored lower stress scores (64.3%) and women had higher stress (48.5%), but without significant 
differences. 
Considering the statistical results, it was inferred that the sociodemographic variables gender (U = 298.5, p = 
.036; U = 271.5, p = .014) monthly family income (H = 10,972, P = .004; H = 7722; p = .021) influenced 
significantly the anxiety and depression levels, and the stress only suffered influence of household income (H = 
7.905; p = .019) (cf. Table 1and 2). 
Table 1. Gender influence on levels of anxiety, depression and stress. 
Gender Male (N=14) Female (N=66) UMW p 
OM OM 
Anxiety 28.82 42.98 298.5 .036* 
Depression 26.89 43.39 271.5 .014* 
Stress 30.43 42.64 321.0 .062 
 
Table 2. Monthly household income influence on levels of anxiety, depression and stress. 
Monthly 
household 
income 
Similar to the national 
minimum wage (N=43) 
Twice the similar to the 
national minimum wage 
(N=21) 
Three times or more than the 
similar to the national minimum 
wage (N=16) KW p 
PM PM PM 
Anxiety 45.67 42.71 23.69 10.972 .004** 
Depression 43.33 45.48 26.38 7.722 .021* 
Stress 44.69 42.48 26.66 7.905 .019* 
 
 
Clinical parameters: perception of pain and general condition of the disease have an effect on anxiety levels (** p 
= .003, p = .000 *** = Depression (** p = .005, p = .000 * **) and stress (p = .080, p = .005 **), although in the 
latter only the general state of the disease has a significant impact (cf. Table 3) 
 
           Table 3. Results of simple linear regression between the pain, the general state of the disease and Anxiety, Depression and Stress. 
Pain r r2(%) t p General condition of 
the disease  
r r2(%) t P 
Anxiety .323 10.3 3.014 .003** Anxiety .446 19.9 4.404 .000*** 
Depression .310 9.6 2.884 .005** Depression .462 21.3 4.601 .000*** 
Stress .197 3.9 1.775 .080 Stress .312 9.7 2.895 .005** 
 
 
The study of people who take biological drugs have lower average order values in anxiety (OM = OM = 40.25 vs 
40.75), depression (OM = 39.76 vs. 41.24) and stress (39.79 vs 41.21), this being the translator of less anxiety 
behaviors, depression and stress, but differences between groups were not statistically significant in these variables 
(anxiety: p = .922), (depression: p = .773) (stress: p = .774), i.e. the levels of anxiety, depression and stress that 
people with rheumatoid arthritis have, are independent of biological medication intake (cf. Table 4). 
 
 
341 Madalena Cunha et al. /  Procedia - Social and Behavioral Sciences  217 ( 2016 )  337 – 343 
 
                           Table 4. U Mann Whitney results between anxiety, depression and stress and intake of biological medication. 
Biological Medication Yes (N=40) No (N=40) UMW p 
OM OM 
Anxiety 40.25 40.75 790.0 .922 
Depression 39.76 41.24 770.5 .773 
Stress 39.79 41.21 771.5 .774 
 
The functional capacity of people with RA was associated positively with the dependent variables, ie, when 
increasing the inability of people to carry out some activities it also increases the anxiety behaviours (r = .253, p = 
.023), depression (r = .337, p = .002) and stress (r = .046, p = .683) (cf. Table 5). 
 
                                Table 5. Results of simple linear regression between functional capacity and anxiety, depression and stress. 
Functional Capacity r r2(%) t p 
Anxiety .253 6.4 .023* 2.313 
Depression .337 11.4 .002** 3.162 
Stress .046 .2 .683 .409 
 
 
To determine the variables that in this study were constituted as predictor factors of the anxiety, stress and 
depression level, it was calculated the multiple linear regression analysis to test the predictive value of some 
independent variables considered of greater clinical interest such as: age, PCR, VS, pain, overall disease activity and 
functional capacity, this way investigating its contribution to the variability of the psycho-emotional state of people 
with rheumatoid arthritis. 
The final predictive model illustrated by this AMOS in figure 1, established that only the general state of illness, 
exerts influence on people with rheumatoid arthritis, being responsible for the variance of about 20% of anxiety, 
21% of depression and 10% of stress. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 - Final model of the influence of the independent variables in anxiety, depression and stress 
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6. Conclusion 
Pain, general disease state and functional capacity are increased in chronic diseases such as rheumatoid arthritis, 
and there is no possibility of healing over time, and improvements in many cases are difficult to reach (Ribeiro, 
Schier, Ornelas, Oliveira e Silva Nardi, 2013; Mcbain, Shipley and Newman, 2013), because, inevitably, they will 
be influenced by the very disfigurement of the disease (Mcbain, Shipley & Newman, 2013). In this sense, it is 
naturally found in these patients increased levels of anxiety, depression and stress. On the other hand, symptoms of 
anxiety and depression aggravate the severity of pain, disease activity and the risk of suicide (Ribeiro, Schier, 
Ornelas, Oliveira, Nardi and Silva, 2013). 
The results of this study support other studies conducted, being extremely important to invest in a effective 
prevention to achieve health gains. It is therefore required a greater investment in the prevention and diagnosis of 
anxiety, depression and stress in rheumatoid arthritis, in order to lessen the severity of disease, reduce functional 
impairment and improve quality of life, wherein health care assistance must include interventions directed to 
screening and treatment of these clinical outbreaks. It is also important to consider these nosological entities in the 
planning of educational / training activities of health professionals, and as such favor a coordinated intervention 
program between the various professionals in the multidisciplinary health team in order to monetize synergies and 
achieve shared goals. 
It is important to stress the need for future research to study other variables including personal representation, 
"disfigurement", coping, self-concept, so that the possession of knowledge can meet best strategies to mitigate / 
eliminate the behaviours of anxiety, depression and stress, avoiding potentiation in worsening health status of people 
with rheumatoid arthritis, also contributing to a better quality of life related to health. 
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